- Adjusted EBITDA Margin: 23.4% for the second quarter (2Q).
- Europe Building Adjusted EBITDA: $87 million.
- Total Revenue: $9.65 billion.
- Americas Materials Sales: $4.41 billion.
- Americas Building Sales: $2.12 billion.
- Europe Materials Sales: $2.40 billion.
- Europe Building Sales: $728 million.
- Year Forecast: Capital expenditure expected between $2.2 billion and $2.4 billion.
- Analyst Ratings: 23 buy ratings, 4 hold ratings, and 2 sell ratings.
A look at CRH Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 3 | |
| Dividend | 3 | |
| Growth | 4 | |
| Resilience | 3 | |
| Momentum | 5 | |
| OVERALL SMART SCORE | 3.6 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
CRH Public Limited Company, a global provider of building materials, is positioned favorably for long-term growth based on its Smartkarma Smart Scores. With a high Momentum score of 5, CRH shows strong potential for continued upward trends in the market. Additionally, the company’s Growth score of 4 reflects promising prospects for expansion and development in various sectors. While the Value, Dividend, and Resilience scores are solid at 3 each, indicating stability in these areas, it is the strong Momentum and Growth scores that suggest CRH’s long-term outlook looks bright.
CRH’s diverse range of architectural, infrastructure, and construction products cater to projects in housing, commercial, and infrastructure sectors globally. This extensive reach contributes to the company’s Resilience score of 3, highlighting its ability to withstand market challenges. Overall, with a mix of steady performance indicators and strong growth potential, CRH appears well-positioned to capitalize on opportunities in the building materials industry for the long term.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
